Editors-in-Chief
- Yukio Ozaki, University of Yamanashi
- Hugo ten Cate, Academic Hospital Maastricht
Founding Editor
- Raul Altman, Centro de Trombosis de Buenos Aires
Articles
-
Original clinical investigation
Thrombosis Journal 2012, 10:7 (18 May 2012)Cross-sectional study of adherence to venous thromboembolism prophylaxis guidelines in hospitalized patients. The Trombo-Brit study
-
Original basic research
Thrombosis Journal 2012, 10:6 (7 May 2012)Endothelial cells influence the sodium nitroprusside mediated inhibition of platelet aggregation by an as yet unkown pathway
-
Original clinical investigation
Thrombosis Journal 2012, 10:5 (30 April 2012)A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
-
Case report
Thrombosis Journal 2012, 10:4 (18 April 2012)Cold autoimmune haemolytic anaemia secondary to Epstein Barr virus infection presenting with peripheral gangrene; case report
-
Original clinical investigation
Thrombosis Journal 2012, 10:3 (11 January 2012)Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study
-
Original basic research
Thrombosis Journal 2012, 10:2 (9 January 2012)SMTP (
Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats - View more articles
Aims & scope
Thrombosis Journal publishes biologically significant findings with clinical relevance in the field of acute and chronic vascular thrombotic disease.
Editors' quotes
Yukio Ozaki
"Treatment and prophylaxis of thrombotic and bleeding disorders is of great importance to worldwide population, and there is a great need to facilitate the research activities related to this field. The aim of Thrombosis Journal is to provide a platform for which these important studies are visible to all members of the scientific community and public."
Hugo ten Cate
"Open access is a critical element in dissemination of knowledge and research data throughout the world. In the field of thrombosis and haemostasis many developments are relevant, not only for the developed world, but also for those in underdeveloped nations where access to journals may be limited. The strength of Thrombosis Journal is that is can be accessed by everyone, everywhere. I strongly encourage scientists to submit their valuable data (clinical and basic research) to Thrombosis Journal, where we provide a platform for the full range of thrombosis and haemostasis related topics (also including case reports and special issue contributions)."
Email updates
Receive periodic news and updates relating to this journal.
RSS
Comments
View more comments